Detalhe da pesquisa
1.
Highly Variable Expression of CYP1A1 in Human Liver and Impact on Pharmacokinetics of Riociguat and Granisetron in Humans.
Chem Res Toxicol
; 32(6): 1115-1122, 2019 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30950278
2.
Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White Paper.
Drug Metab Dispos
; 44(5): 617-23, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26669328
3.
Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.
Mol Cell
; 31(3): 438-48, 2008 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-18691976
4.
In vivo Metabolism of Nifurtimox and the Drug-Drug Interaction Potential Including its Major Metabolites.
Curr Drug Metab
; 24(8): 599-610, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592798
5.
Proteomics strategy for quantitative protein interaction profiling in cell extracts.
Nat Methods
; 6(10): 741-4, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19749761
6.
Results from Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Effect of Finerenone on the Pharmacokinetics of Comedications.
Eur J Drug Metab Pharmacokinet
; 45(4): 433-444, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32125665
7.
Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF).
J Med Chem
; 63(20): 11639-11662, 2020 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969660
8.
Drug-Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies.
Eur J Drug Metab Pharmacokinet
; 44(6): 747-759, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31571146
9.
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor N-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile.
J Med Chem
; 62(24): 11194-11217, 2019 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31746599